「The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy」の関連論文
-
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumors
-
Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy
-
Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth
-
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib
-
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer
-
NOTCH3 limits the epithelial-mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer
-
Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
-
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
-
Tumor-suppressive role of the musculoaponeurotic fibrosarcoma gene in colorectal cancer
-
The Effect of Chemotherapy on Stroke Risk in Cancer Patients
-
The regenerative treatment of costal osteochondral graft implantation for partial growth arrest using a rabbit model
-
Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma
-
CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer
-
Efficacy of Autologous Skeletal Myoblast Cell Sheet Transplantation for Liver Regeneration in Liver Failure
-
Knee Extensor Weakness Potently Predicts Postoperative Outcomes in Older Gastrointestinal Cancer Patients
-
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
-
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody
-
Novel Strategy for the Management of Cervical Multicystic Diseases
-
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
-
Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer
-
PERSONALIZED VENTILATORY STRATEGY BASED ON LUNG RECRUITABLITY IN COVID-19-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME: A PROSPECTIVE CLINICAL STUDY
-
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinoma
-
A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis
-
Novel, infection-free, advanced hemostatic material: physical properties and preclinical efficacy
-
Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy
-
Prognostic factors for bone metastases from head and neck squamous cell carcinoma: A case series of 97 patients
-
Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas : identifying predictors of 50% volume reduction
-
Clinical characteristics of COVID-19 infection in a dialysis center during a nosocomial outbreak
-
Increased anti-oxidative action compensates for collagen tissue degeneration in vitiligo dermis
-
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
-
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with autoantibody-mediated neuroimmunology
-
Inhibition of cIAP1 in the effective suppression of chemotherapy-resistant hepatoblastoma
-
Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours
-
Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening
-
Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation
-
Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [211At] NaAt in Mice: A Revisit
-
Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer
-
The kinetics of signaling through the common FcRγ chain determine cytokine profiles in dendritic cells
-
Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer
-
Vitamin K intake and risk of lung cancer: the Japan Collaborative Cohort Study
-
Prevalence of human papillomavirus in oral gargles and tonsillar washings
-
Long-term Outcomes of Radiation Therapy for Prostate Cancer in Elderly Patients Aged ≥75 Years
-
Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
-
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex
-
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer
-
Purpose in life (Ikigai) and employment status in relation to cardiovascular mortality: the Japan Collaborative Cohort Study
-
Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota
-
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
-
Use of a convolutional neural network for classifying microvessels of superficial esophageal squamous cell carcinomas
-
A novel model to predict positive prostate biopsy based on serum androgen level